how to not gain weight back after semaglutide Ozempic Butt Explained: Avoid It Why Am I Not Losing

Find out its efficacy, comparison to Wegovy and Mounjaro, and when it will be available.

Our functional pharmacist work with you to maximize weight loss and minimize side effects.

Once Monthly GLP-1 Maridebart cafraglutide is an investigational once-monthly injectable drug developed by Amgen that shows significant promise for treating obesity and Type 2 diabetes

Semaglutide may improve fertility outcomes in people with obesity-related infertility by restoring metabolic function and hormonal balance

Combatting the opioid overdose epidemic has some good news emerging from the medicines sector, with per capita prescribing of opioids down 67% since its apex in 2011

Learn how semaglutide's GLP-1 mechanism outperforms NAD+ supplementation in clinical trials and which therapy matches your health goals